New test may simplify MS diagnosis
NCT ID NCT07183020
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 23 times
Summary
This study is testing whether a protein called kappa free light chains (KFLC) in spinal fluid can help diagnose multiple sclerosis (MS) as accurately as the current standard test. Researchers will compare results from over 1,100 adults diagnosed with MS or a first MS-like episode. If KFLC works as well, it could make diagnosis faster and easier.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medizinische Hochschule Hannover / Hannover Medical School
Hanover, Lower Saxony, 30625, Germany
Conditions
Explore the condition pages connected to this study.